Cardiatec

At the Heart of Innovation

Cambridge, United Kingdom · Founded 2021 · $1.9M raised

Headquarters
Cambridge
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$1.9M
Last Round
$1.9M Pre-SeedJul 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

CardiaTec Biosciences is a University of Cambridge spinout applying artificial intelligence to large-scale multi-omic data to discover the next generation of cardiovascular disease drug targets. The company has built a global network of 65 hospitals to develop the largest proprietary human cardiac multiomics dataset, enriched with clinical annotations. Founded in 2021 by Prof. Namshik Han, Raphael Peralta, and Thelma Zablocki, CardiaTec pursues target discovery, drug discovery, and personalised medicine across cardiovascular indications.

Summary

Cardiatec is an Artificial Intelligence company based in Cambridge, United Kingdom, founded in 2021. It has raised $1.9M in total across 1 round, most recently a $1.9M Pre-Seed round in Jul 2022. Investors include Laidlaw Scholars Ventures, APEX Ventures and Cambridge Enterprise.

Funding History

Pre-seedPre-SeedJul 2022
$1.9M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cardiatec on Indexed.vc
<a href="https://indexed.vc/companies/cardiatec"><img src="https://indexed.vc/api/badge/company/cardiatec" alt="Cardiatec on Indexed.vc" width="260" height="76" /></a>